Capital Research Global Investors
Position in DNLI — Denali Therapeutics Inc.
CIK 1422848
Los Angeles, CA
Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$65,992,813
+$17,712,724 QoQ
Shares Held
2,565,817
+2.0% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 290 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $14,161,458,348 across 17 Biotechnology names. DNLI ranks #12 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,490,637 | $9,681,584,117 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,750,699 | $2,935,252,919 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,504,387 | $200,521,024 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
5,344,701 | $199,197,006 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,621,890 | $185,236,528 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,532,303 | $170,131,602 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
1,388,881 | $159,262,984 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,686,625 | $143,683,583 |
All Filings in DNLI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,992,813 | 2,565,817 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $48,280,089 | 2,514,588 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $61,569,818 | 3,729,244 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $69,127,658 | 4,760,858 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $66,460,600 | 4,750,579 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $64,782,037 | 4,765,137 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $111,625,560 | 5,477,211 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $230,392,490 | 7,909,114 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $165,478,096 | 7,126,533 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $124,145,117 | 6,049,957 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $62,438,470 | 2,909,528 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $59,421,063 | 2,880,323 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $83,739,110 | 2,837,652 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $56,881,704 | 2,468,824 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $62,868,454 | 2,260,642 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,693,569 | 87,767 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||